Cal. Code Regs. tit. 22 § 59999

Current through Register 2024 Notice Reg. No. 20, May 17, 2024
Section 59999 - Medi-Cal Drug Formulary. [Repealed]

Cal. Code Regs. Tit. 22, § 59999

1. Amendment of subsection (b), page 58, filed 1-21-88; operative 3-1-88 (Register 88, No. 5). For prior history, see Register 87, No. 47.
2. Amendment of subsection (b), page 61, filed 1-21-88; operative 3-1-88 (Register 88, No. 5).
3. Amendment of subsections (b) and (e) filed 1-21-88; operative 3-1-88 (Register 88, No. 5).
4. Amendment of subsection (b) filed 3-7-88; operative 5-1-88 (Register 88, No. 12).
5. Amendment of subsections (b) and (e) filed 3-9-88; operative 5-1-88 (Register 88, No. 12).
6. Amendment of subsections (c) and (e) filed 3-10-88; operative 5-1-88 (Register 88, No. 12).
7. Amendment of subsections (b) and (e) filed 3-23-88; operative 5-1-88 (Register 88, No. 14).
8. Amendment of subsection (b) filed 4-6-88; operative 4-6-88 (Register 88, No. 17).
9. Amendment of subsections (b) and (e) filed 7-13-88; operative 9-15-88 (Register 88, No. 29).
10. Amendment of subsection (b) filed 8-9-88; operative 8-9-88 (Register 88, No. 33).
11. Amendment of subsections (b) and (e) filed 8-26-88; operative 9-25-88 (Register 88, No. 36).
12. Amendment of subsections (b) and (e) filed 8-29-88; operative 10-1-88 (Register 88, No. 39).
13. Amendment of subsection (b) filed 9-22-88; operative 10-22-88 (Register 88, No. 42).
14. Editorial correction of printing error (Register 88, No. 45).
15. Amendment of subsection (b) filed 11-2-88; operative 12-2-88 (Register 88, No. 45).
16. Amendment of subsections (b) and (e) filed 11-21-88; operative 12-2-88 (Register 88, No. 45).
17. Amendment of subsection (b) filed 12-19-88 pursuant to Welfare and Institutions Code section 14105.91; operative 12-19-88 (Register 88, No. 52).
18. Amendment of subsections (b) and (e) filed 1-17-89; operative 3-1-89 (Register 89, No. 4).
19. Editorial correction of Erythromycin printing error (Register 89, No. 11).
20. Amendment of subsections (b), (c) and (e) filed 4-26-89 pursuant to Welfare and Institutions Code section 14105.91; operative 4-26-89 (Register 89, No. 17).
21. Amendment of subsections (b) and (e) adding Lisinopril filed 5-15-89; operative 6-14-89 (Register 89, No. 21).
22. Amendment of subsections (b) and (e) filed 5-18-89 (Register 89, No. 21). Pentamidine was approved by the United States Food and Drug Administration (Department of Health and Human Services Medicaid Regional Memorandum No. 89-9) and pursuant to Welfare and Institutions Code section 14105.43 is deemed to be approved for addition to the Medi-Cal drug formulary only for the purpose of treating AIDS or an AIDS-related condition for the period prior to the completion of the procedures established pursuant to Welfare and Institutions Code section 14105.4.
23. Amendment of subsections (b) and (e) adding Ciprofloxacin filed 5-24-89; operative 6-23-89 (Register 89, No. 24).
24. Amendment of subsection (b) adding Topical Oil 120cc to Fluocinolone 0.01% filed 8-25-89; operative 8-25-89 (Register 89, No. 36).
25. Amendment of subsections (a), (c) and (e) filed 9-5-89; operative 10-1-89 (Register 89, No. 36).
26. Amendment of subsection (b) filed 9-20-89; operative 9-20-89 (Register 89, No. 40). Pentamidine, approved by the U.S. Food and Drug Administration, and pursuant to Welfare and Institutions Code section 14105.43 is deemed to be approved for addition to the Medi-Cal drug formulary only for the purpose of treating AIDS or an AIDS-related condition for the period prior to the completion of the procedures established pursuant to Welfare and Institutions Code section 14105.4.
27. Amendment of subsection (b) adding injection dosage form of Sodium Chloride filed 10-19-89; operative 12-1-89 (Register 89, No. 44).
28. Amendment of subsections (b) and (e) adding Heparin Lock Flush Solution filed 10-30-89; operative 12-1-89 (Register 89, No. 44).
29. Editorial correction of spelling errors (Glucocorticoids and Trisalicylate) (Register 89, No. 44).
30. Amendment of subsection (b) adding Ganciclovir Sodium filed 10-31-89 pursuant to Welfare and Institutions Code section 14105.43; operative 10-31-89 (Register 89, No. 48).
31. Amendment of subsections (b) and (e) deleting Isotretinoin filed 12-6-89; operative 2-15-90 (Register 89, No. 52).
32. Amendment of subsections (b) and (e) adding Pyrazinamide filed 2-22-90; operative 3-24-90 (Register 90, No. 9).
33. Amendment of subsections (b) and (e) adding Calcitroil filed 3-1-90; operative 3-31-90 (Register 90, No. 9).
34. Amendment of subsection (b) filed 3-2-90, operative 2-15-90 (Register 90, No. 19). Zidovudine, approved by the U.S. Food and Drug Administration, and pursuant to Welfare and Institutions Code sections 14105.43 and 14105.91 is deemed approved for addition to the Medical drug formulary only for the purpose of treating AIDS or an AIDS-related condition for the period prior to the completion of the procedures established pursuant to Welfare and Institutions Code section 14105.4.
35. Amendment of subsection (b) (Albuterol) filed 3-7-90 pursuant to Welfare and Institutions Code section 14105.91; operative 3-7-90 (Register 90, No. 19).
36. Amendment of subsection (b) (Cromolyn Sodium) filed 3-15-90 pursuant to Welfare and Institutions Code section 14105.91; operative 3-15-90 (Register 90, No. 19).
37. Amendment of subsection (b) adding additional dosage of drug Guanfacine HCL to Medi-Cal Drug Formulary filed 3-22-90 pursuant to Welfare and Institutions Code section 14105.91; operative 3-22-90 (Register 90, No. 19).
38. Amendment of subsection (b) (Zidovudine) filed 4-25-90; operative 4-25-90 (Register 90, No. 19).
39. Amendment of subsections (b) and (e) filed 4-25-90; operative 4-15-90 (Register 90, No. 26). Fluconazole, approved by the U.S. Food and Drug Administration, and pursuant to Welfare and Institutions Code sections 14105.43 and 14105.91 is deemed approved for addition to the Medi-Cal Drug Formulary only for the purpose of treating AIDS or an AIDS-related condition for the period prior to the completion of the procedures established pursuant to Welfare and Institutions Code section 14105.4.
40. Amendment of subsections (b) and (e) filed 5-1-90; operative 7-1-90 (Register 90, No. 26).
41. Amendment of subsections (c) and (e) filed 6-15-90; operative 7-15-90 (Register 90, No. 32).
42. Amendment of subsection (b) Gentamicin and subsection (e) adding Gentamicin filed 6-22-90; operative 6-22-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
43. Amendment of subsection (b) Haloperidol Decanoate filed 6-22-90; operative 6-22-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
44. Amendment of subsection (b) Rifampin filed 6-22-90; operative 6-22-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
45. Amendment of subsection (b) Levothyroxine Sodium filed 6-22-90; operative 6-22-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
46. Amendment of subsection (b) Nifedipine filed 7-2-90; operative 7-2-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
47. Amendment of subsections (b) and (e) (Metronidazole) filed 7-5-90; operative 7-5-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
48. Amendment of subsections (b) and (e) adding Nizatidine filed 7-11-90; operative 8-10-90 (Register 90, No. 32).
49. Amendment of subsections (b) and (e) adding Permethrin filed 7-18-90; operative 8-17-90 (Register 90, No. 32).
50. Amendment of subsections (b) and (e) adding Cefuroxime Axetil filed 7-19-90; operative 8-18-90 (Register 90, No. 32).
51. Editorial correction of printing error of subsection (b) Sodium Chloride filed 8-1-90; operative 8-1-90 (Register 90, No. 32).
52. Addition of Lovastatin to (b) and (e) filed 7-30-90; operative 7-30-90 (Register 90, No. 38).
53. Repealer filed 4-22-91 as an emergency pursuant to Statutes of 1990, chapter 456, section 36, p. 1658-1659; operative 5-22-91 (Register 91, No. 27). A Certificate of Compliance must be transmitted to OAL by 9-19-91 or emergency language will be repealed by operation of law on the following day.
54. Repealer of section refiled 9-19-91 as an emergency; operative 9-20-91 (Register 92, No. 4). A Certificate of Compliance must be transmitted to OAL 1-20-92 or emergency language will be repealed on the following day.
55. Repealer of section refiled 1-23-92 as an emergency; operative 1-17-92 (Register 92, No. 25). A Certificate of Compliance must be transmitted to OAL 5-22-92 or emergency language will be repealed by operation of law on the following day.
56. Certificate of Compliance as to 1-23-92 order transmitted to OAL 5-22-92 and filed 7-6-92 (Register 92, No. 28).

Note: Authority cited: Sections 14105, 14105.42, 14105.91 and 14124.5, Welfare and Institutions Code; and Section 208, Health and Safety Code. Reference: Sections 14053, 14105, 14105.43, 14105.91 and 14132, Welfare and Institutions Code.

1. Amendment of subsection (b), page 58, filed 1-21-88; operative 3-1-88 (Register 88, No. 5). For prior history, see Register 87, No. 47.
2. Amendment of subsection (b), page 61, filed 1-21-88; operative 3-1-88 (Register 88, No. 5).
3. Amendment of subsections (b) and (e) filed 1-21-88; operative 3-1-88 (Register 88, No. 5).
4. Amendment of subsection (b) filed 3-7-88; operative 5-1-88 (Register 88, No. 12).
5. Amendment of subsections (b) and (e) filed 3-9-88; operative 5-1-88 (Register 88, No. 12).
6. Amendment of subsections (c) and (e) filed 3-10-88; operative 5-1-88 (Register 88, No. 12).
7. Amendment of subsections (b) and (e) filed 3-23-88; operative 5-1-88 (Register 88, No. 14).
8. Amendment of subsection (b) filed 4-6-88; operative 4-6-88 (Register 88, No. 17).
9. Amendment of subsections (b) and (e) filed 7-13-88; operative 9-15-88 (Register 88, No. 29).
10. Amendment of subsection (b) filed 8-9-88; operative 8-9-88 (Register 88, No. 33).
11. Amendment of subsections (b) and (e) filed 8-26-88; operative 9-25-88 (Register 88, No. 36).
12. Amendment of subsections (b) and (e) filed 8-29-88; operative 10-1-88 (Register 88, No. 39).
13. Amendment of subsection (b) filed 9-22-88; operative 10-22-88 (Register 88, No. 42).
14. Editorial correction of printing error (Register 88, No. 45).
15. Amendment of subsection (b) filed 11-2-88; operative 12-2-88 (Register 88, No. 45).
16. Amendment of subsections (b) and (e) filed 11-21-88; operative 12-2-88 (Register 88, No. 45).
17. Amendment of subsection (b) filed 12-19-88 pursuant to Welfare and Institutions Code section 14105.91; operative 12-19-88 (Register 88, No. 52).
18. Amendment of subsections (b) and (e) filed 1-17-89; operative 3-1-89 (Register 89, No. 4).
19. Editorial correction of Erythromycin printing error (Register 89, No. 11).
20. Amendment of subsections (b), (c) and (e) filed 4-26-89 pursuant to Welfare and Institutions Code section 14105.91; operative 4-26-89 (Register 89, No. 17).
21. Amendment of subsections (b) and (e) adding Lisinopril filed 5-15-89; operative 6-14-89 (Register 89, No. 21).
22. Amendment of subsections (b) and (e) filed 5-18-89 (Register 89, No. 21). Pentamidine was approved by the United States Food and Drug Administration (Department of Health and Human Services Medicaid Regional Memorandum No. 89-9) and pursuant to Welfare and Institutions Code section 14105.43 is deemed to be approved for addition to the Medi-Cal drug formulary only for the purpose of treating AIDS or an AIDS-related condition for the period prior to the completion of the procedures established pursuant to Welfare and Institutions Code section 14105.4.
23. Amendment of subsections (b) and (e) adding Ciprofloxacin filed 5-24-89; operative 6-23-89 (Register 89, No. 24).
24. Amendment of subsection (b) adding Topical Oil 120cc to Fluocinolone 0.01% filed 8-25-89; operative 8-25-89 (Register 89, No. 36).
25. Amendment of subsections (a), (c) and (e) filed 9-5-89; operative 10-1-89 (Register 89, No. 36).
26. Amendment of subsection (b) filed 9-20-89; operative 9-20-89 (Register 89, No. 40). Pentamidine, approved by the U.S. Food and Drug Administration, and pursuant to Welfare and Institutions Code section 14105.43 is deemed to be approved for addition to the Medi-Cal drug formulary only for the purpose of treating AIDS or an AIDS-related condition for the period prior to the completion of the procedures established pursuant to Welfare and Institutions Code section 14105.4.
27. Amendment of subsection (b) adding injection dosage form of Sodium Chloride filed 10-19-89; operative 12-1-89 (Register 89, No. 44).
28. Amendment of subsections (b) and (e) adding Heparin Lock Flush Solution filed 10-30-89; operative 12-1-89 (Register 89, No. 44).
29. Editorial correction of spelling errors (Glucocorticoids and Trisalicylate) (Register 89, No. 44).
30. Amendment of subsection (b) adding Ganciclovir Sodium filed 10-31-89 pursuant to Welfare and Institutions Code section 14105.43; operative 10-31-89 (Register 89, No. 48).
31. Amendment of subsections (b) and (e) deleting Isotretinoin filed 12-6-89; operative 2-15-90 (Register 89, No. 52).
32. Amendment of subsections (b) and (e) adding Pyrazinamide filed 2-22-90; operative 3-24-90 (Register 90, No. 9).
33. Amendment of subsections (b) and (e) adding Calcitroil filed 3-1-90; operative 3-31-90 (Register 90, No. 9).
34. Amendment of subsection (b) filed 3-2-90, operative 2-15-90 (Register 90, No. 19). Zidovudine, approved by the U.S. Food and Drug Administration, and pursuant to Welfare and Institutions Code sections 14105.43 and 14105.91 is deemed approved for addition to the Medical drug formulary only for the purpose of treating AIDS or an AIDS-related condition for the period prior to the completion of the procedures established pursuant to Welfare and Institutions Code section 14105.4.
35. Amendment of subsection (b) (Albuterol) filed 3-7-90 pursuant to Welfare and Institutions Code section 14105.91; operative 3-7-90 (Register 90, No. 19).
36. Amendment of subsection (b) (Cromolyn Sodium) filed 3-15-90 pursuant to Welfare and Institutions Code section 14105.91; operative 3-15-90 (Register 90, No. 19).
37. Amendment of subsection (b) adding additional dosage of drug Guanfacine HCL to Medi-Cal Drug Formulary filed 3-22-90 pursuant to Welfare and Institutions Code section 14105.91; operative 3-22-90 (Register 90, No. 19).
38. Amendment of subsection (b) (Zidovudine) filed 4-25-90; operative 4-25-90 (Register 90, No. 19).
39. Amendment of subsections (b) and (e) filed 4-25-90; operative 4-15-90 (Register 90, No. 26). Fluconazole, approved by the U.S. Food and Drug Administration, and pursuant to Welfare and Institutions Code sections 14105.43 and 14105.91 is deemed approved for addition to the Medi-Cal Drug Formulary only for the purpose of treating AIDS or an AIDS-related condition for the period prior to the completion of the procedures established pursuant to Welfare and Institutions Code section 14105.4.
40. Amendment of subsections (b) and (e) filed 5-1-90; operative 7-1-90 (Register 90, No. 26).
41. Amendment of subsections (c) and (e) filed 6-15-90; operative 7-15-90 (Register 90, No. 32).
42. Amendment of subsection (b) Gentamicin and subsection (e) adding Gentamicin filed 6-22-90; operative 6-22-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
43. Amendment of subsection (b) Haloperidol Decanoate filed 6-22-90; operative 6-22-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
44. Amendment of subsection (b) Rifampin filed 6-22-90; operative 6-22-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
45. Amendment of subsection (b) Levothyroxine Sodium filed 6-22-90; operative 6-22-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
46. Amendment of subsection (b) Nifedipine filed 7-2-90; operative 7-2-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
47. Amendment of subsections (b) and (e) (Metronidazole) filed 7-5-90; operative 7-5-90 pursuant to Welfare and Institutions Code section 14105.91 (Register 90, No. 32).
48. Amendment of subsections (b) and (e) adding Nizatidine filed 7-11-90; operative 8-10-90 (Register 90, No. 32).
49. Amendment of subsections (b) and (e) adding Permethrin filed 7-18-90; operative 8-17-90 (Register 90, No. 32).
50. Amendment of subsections (b) and (e) adding Cefuroxime Axetil filed 7-19-90; operative 8-18-90 (Register 90, No. 32).
51. Editorial correction of printing error of subsection (b) Sodium Chloride filed 8-1-90; operative 8-1-90 (Register 90, No. 32).
52. Addition of Lovastatin to (b) and (e) filed 7-30-90; operative 7-30-90 (Register 90, No. 38).
53. Repealer filed 4-22-91 as an emergency pursuant to Statutes of 1990, chapter 456, section 36, p. 1658-1659; operative 5-22-91 (Register 91, No. 27). A Certificate of Compliance must be transmitted to OAL by 9-19-91 or emergency language will be repealed by operation of law on the following day.
54. Repealer of section refiled 9-19-91 as an emergency; operative 9-20-91 (Register 92, No. 4). A Certificate of Compliance must be transmitted to OAL 1-20-92 or emergency language will be repealed on the following day.
55. Repealer of section refiled 1-23-92 as an emergency; operative 1-17-92 (Register 92, No. 25). A Certificate of Compliance must be transmitted to OAL 5-22-92 or emergency language will be repealed by operation of law on the following day.
56. Certificate of Compliance as to 1-23-92 order transmitted to OAL 5-22-92 and filed 7-6-92 (Register 92, No. 28).